We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELVT
2326
DELISTED
Elevate Credit, Inc.
ELVT
| $88K | ﹤0.01% |
79,600
-103,700
| -57% | -$188K |
|
2327
Solid Biosciences
SLDB
$785M
| $87K | ﹤0.01% |
12,473
-2,634
| -17% | -$26.6K |
|
2328
Kodak
KODK
$812M
| $86K | ﹤0.01% |
18,800
-1,600
| -8% | -$8.74K |
|
|
NEUE
2329
DELISTED
NeueHealth
NEUE
| $86K | ﹤0.01% |
1,021
+272
| +36% | +$36.1K |
|
|
AFMD
2330
DELISTED
Affimed
AFMD
| $83K | ﹤0.01% |
4,027
-6,810
| -63% | -$189K |
|
|
CKPT
2331
DELISTED
Checkpoint Therapeutics
CKPT
| $83K | ﹤0.01% |
8,010
-7,090
| -47% | -$84.5K |
|
|
CTHR
2332
DELISTED
Charles & Colvard Ltd
CTHR
| $83K | ﹤0.01% |
8,520
-4,450
| -34% | -$54.8K |
|
2333
Standard BioTools
LAB
$311M
| $82K | ﹤0.01% |
74,600
+800
| +1% | +$1.21K |
|
|
APTO
2334
DELISTED
Aptose Biosciences, Inc.
APTO
| $82K | ﹤0.01% |
306
-85
| -22% | -$29.3K |
|
|
APTX
2335
DELISTED
Aptinyx Inc. Common Stock
APTX
| $82K | ﹤0.01% |
222,200
-11,200
| -5% | -$5.61K |
|
|
AATC
2336
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
| $81K | ﹤0.01% |
17,700
-1,900
| -10% | -$9.63K |
|
2337
Gaia
GAIA
$47.6M
| $80K | ﹤0.01% |
32,800
-11,200
| -25% | -$39.2K |
|
2338
SkyWater Technology
SKYT
$1.53B
| $80K | ﹤0.01% |
+10,500
| New | +$124K |
|
2339
CVD Equipment Corp
CVV
$46.7M
| $79K | ﹤0.01% |
15,200
-4,400
| -22% | -$21.9K |
|
2340
Wheels Up
UP
$200M
| $79K | ﹤0.01% |
342
-525
| -61% | -$210K |
|
|
DOYU
2341
DouYu International Holdings
DOYU
$140M
| $78K | ﹤0.01% |
7,830
+880
| +13% | +$11.1K |
|
2342
Orion Energy Systems
OESX
$41.8M
| $78K | ﹤0.01% |
5,020
-800
| -14% | -$14.2K |
|
|
AHT
2343
Ashford Hospitality Trust
AHT
$20.9M
| $76K | ﹤0.01% |
+1,120
| New | +$99.4K |
|
2344
Lightwave Logic
LWLG
$887M
| $76K | ﹤0.01% |
10,300
+100
| +1% | +$937 |
|
2345
Vuzix
VUZI
$187M
| $76K | ﹤0.01% |
13,100
-209,600
| -94% | -$1.62M |
|
2346
Quantum Corp
QMCO
$444M
| $72K | ﹤0.01% |
3,350
-40
| -1% | -$1.28K |
|
2347
Shattuck Labs
STTK
$651M
| $71K | ﹤0.01% |
26,300
-14,500
| -36% | -$54.4K |
|
|
TTSH
2348
DELISTED
Tile Shop Holdings
TTSH
| $70K | ﹤0.01% |
19,800
+700
| +4% | +$2.51K |
|
|
MACK
2349
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $70K | ﹤0.01% |
18,681
-300
| -2% | -$1.39K |
|
|
AIFA
2350
All In FutureTech Alliance Inc
AIFA
$11.4M
| $68K | ﹤0.01% |
9,733
-3,967
| -29% | -$34.6K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.